Profile
Full Name
Passage Bio, Inc.Ticker Symbol
PASGExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
February 28, 2020Indexes
Not includedWebsite
http://www.passagebio.comEmployees
60Key Details
Price
$0.36(+0.28%)
Market cap
$22.56M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.07(+42.47% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Passage Bio doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 4, 25 Chardan Capital
BuyNov 14, 24 Chardan Capital
BuyNov 14, 24 Canaccord Genuity
BuySep 17, 24 Canaccord Genuity
BuySep 3, 24 Rodman & Renshaw
BuyMay 15, 24 Canaccord Genuity
BuyMar 5, 24 Canaccord Genuity
BuyNov 14, 23 Raymond James
OutperformAug 8, 23 Chardan Capital
BuyMay 12, 23 Raymond James
OutperformInstitutional Ownership
- What is the ticker symbol for Passage Bio?
- Does Passage Bio pay dividends?
- What sector is Passage Bio in?
- What industry is Passage Bio in?
- What country is Passage Bio based in?
- When did Passage Bio go public?
- Is Passage Bio in the S&P 500?
- Is Passage Bio in the NASDAQ 100?
- Is Passage Bio in the Dow Jones?
- When was Passage Bio's last earnings report?
- When does Passage Bio report earnings?
- Should I buy Passage Bio stock now?
What is the ticker symbol for Passage Bio?
The ticker symbol for Passage Bio is NASDAQ:PASG
Does Passage Bio pay dividends?
No, Passage Bio does not pay dividends
What sector is Passage Bio in?
Passage Bio is in the Healthcare sector
What industry is Passage Bio in?
Passage Bio is in the Biotechnology industry
What country is Passage Bio based in?
Passage Bio is headquartered in United States
When did Passage Bio go public?
Passage Bio's initial public offering (IPO) was on February 28, 2020
Is Passage Bio in the S&P 500?
No, Passage Bio is not included in the S&P 500 index
Is Passage Bio in the NASDAQ 100?
No, Passage Bio is not included in the NASDAQ 100 index
Is Passage Bio in the Dow Jones?
No, Passage Bio is not included in the Dow Jones index
When was Passage Bio's last earnings report?
Passage Bio's most recent earnings report was on Mar 4, 2025
When does Passage Bio report earnings?
The next expected earnings date for Passage Bio is May 14, 2025
Should I buy Passage Bio stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions